기계식 인공호흡기 시장 규모, 점유율, 동향 분석 보고서 : 환기 모드별, 인터페이스별, 지역별 및 부문별 예측(2026-2033년)

Mechanical Ventilator Market Summary

The global mechanical ventilator market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.4 billion in 2026 to USD 5.5 billion by 2033, at a CAGR of 7.1% from 2026 to 2033. North America held the largest global revenue share of 41.6% in 2025. The increasing prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, asthma, obstructive sleep apnea, exertional dyspnea, and pulmonary embolism is fueling the growth of the mechanical ventilator industry.

Global Mechanical Ventilator Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the mechanical ventilator market report based on interphase, and region:

• Interphase Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Invasive
  • Product Type
  • Ventilators
  • Accessories
  • End use
  • Critical care
  • Others
• Non-invasive
  • Product Type
  • Ventilators
  • Product Type
  • Critical Care
  • Neonatal
  • Transport & Portable
  • Others
  • End use
  • Acute care
  • Post-acute
  • Home care
  • Critical care
  • Accessories
• Non-Invasive Ventilation Mode Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• CPAP
• BiPAP
• Others
• Non-Invasive Indication Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• COPD
• Neuromuscular diseases
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Interphase
  • 1.2.2. Ventilation Mode
  • 1.2.3. Indication
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Interphase outlook
  • 2.2.2. Ventilation Mode Outlook
  • 2.2.3. Indication Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Mechanical Ventilator Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing In Prevalence Of Respiratory Diseases
    • 3.2.1.2. Technological advancement
    • 3.2.1.3. Increasing Number Of Government Initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Capital Intensive Nature
  • 3.2.3. Market Challenge Analysis
  • 3.2.4. Market Opportunity Analysis
• 3.3. Mechanical Ventilator Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
• 3.4. Pricing Analysis, at Regional Level
  • 3.4.1. North America
  • 3.4.2. Europe
  • 3.4.3. Asia Pacific
  • 3.4.4. Latin America
  • 3.4.5. MEA
• 3.5. Unmet Need in the Market, at Regional Level
  • 3.5.1. North America
  • 3.5.2. Europe
  • 3.5.3. Asia Pacific
  • 3.5.4. Latin America
  • 3.5.5. MEA

Chapter 4. Mechanical Ventilator Market: Interphase Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Mechanical Ventilator Market: Interphase Movement Analysis, USD Million/Billion, 2025 & 2033
• 4.3. Invasive
  • 4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 4.3.2. Product Type
    • 4.3.2.1. Ventilators
      • 4.3.2.1.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
      • 4.3.2.1.2. Accessories
        • 4.3.2.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 4.3.3. End Use
    • 4.3.3.1.1. Critical Care
    • 4.3.3.1.2. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 4.3.3.1.3. Others
      • 4.3.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
• 4.4. Non-Invasive
  • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.2. Product Type
    • 4.4.2.1. Ventilators
      • 4.4.2.1.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.2.1.2. Product Type
        • 4.4.2.1.2.1. Critical Care
          • 4.4.2.1.2.1.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.2.2. Neonatal
          • 4.4.2.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.2.3. Transport & Portable
          • 4.4.2.1.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.2.4. Others
          • 4.4.2.1.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.2.1.3. End Use
        • 4.4.2.1.3.1. Acute care
          • 4.4.2.1.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.3.2. Post-acute
          • 4.4.2.1.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.3.3. Home care
          • 4.4.2.1.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
        • 4.4.2.1.3.4. Critical care
          • 4.4.2.1.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.2.1.4. Accessories
        • 4.4.2.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 5. Non-Invasive Mechanical Ventilator Market: Ventilation Mode Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Mechanical Ventilator Market: Ventilation Mode Movement Analysis, USD Million/Billion, 2025 & 2033
  • 5.2.1. CPAP
    • 5.2.1.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.2.2. BiPAP
    • 5.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.2.3. Others
    • 5.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 6. Non-Invasive Mechanical Ventilator Market: Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Mechanical Ventilator Market: Indication Movement Analysis, USD Million/Billion, 2025 & 2033
  • 6.2.1. COPD
    • 6.2.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.2.2. Neuromuscular diseases
    • 6.2.2.1. Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.2.3. Others
    • 6.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Mechanical Ventilator Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million/Billion)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.9. Russia
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive scenario
    • 7.5.9.4. Russia market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5.10. Switzerland
    • 7.5.10.1. Key country dynamics
    • 7.5.10.2. Regulatory framework
    • 7.5.10.3. Competitive scenario
    • 7.5.10.4. Switzerland market estimates and forecasts 2021 to 2033 (USD Million/Billion)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million/Billion)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million/Billion)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 8. Competitive Landscape

• 8.1. Company Market Position Analysis, 2025
• 8.2. Key Company Market Analysis, at the global and regional level, 2025
• 8.3. Company Categorization
• 8.4. Exit Strategies of Existing Market Players and Their Impact on Market Competitors
• 8.5. Company Profiles/Listing
  • 8.5.1. ResMed
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Fisher & Paykel Healthcare Limited
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Dragerwerk AG & Co. KGaA
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Getinge AB
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Air Liquide Medical Systems
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. GE HealthCare
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Hamilton Medical
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Smiths Medical (ICU Medical)
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Bio-Med Devices (Air Liquide Healthcare)
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. ZOLL Medical Corporation (Asahi Kasei Corporation)
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. aXcent Medical GmbH
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Magnamed
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Avasarala Technologies Limited
    • 8.5.13.1. Overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Airon Corporation
    • 8.5.14.1. Overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. HEYER Medical AG
    • 8.5.15.1. Overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.5.16.1. Overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Nihon Kohden Corporation
    • 8.5.17.1. Overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. Schiller AG
    • 8.5.18.1. Overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product benchmarking
    • 8.5.18.4. Strategic initiatives